Dana-Farber Cancer Institute/dana-farber.org
Jun 26, 2025, 07:32
Boston Planning and Development Agency Approved the Design of New Freestanding Inpatient Cancer Hospital – Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn:
“We’re excited to share that the Boston Planning and Development Agency unanimously approved the design of our new freestanding inpatient cancer hospital. This pivotal milestone propels us toward the construction of a 300-bed hospital – the first of its kind in New England – designed exclusively around the needs of cancer patients.
This new hospital reflects our aspiration to elevate the patient experience, seamlessly connecting inpatient, outpatient, and research services for a truly integrated continuum of care. Built in close clinical collaboration with Beth Israel Deaconess Medical Center and Harvard Medical Faculty Physicians at BIDMC, this landmark partnership will harness the best of our institutions – combining our oncology experience with BIDMC’s academic strength to better serve patients and families.
Together, we’re raising more than just a hospital – we’re raising the standard of cancer care for everyone.”
Read further and watch the video attached to this post.
More posts featuring Dana-Farber Cancer Institute on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 30, 2025, 16:43
Jun 30, 2025, 16:33
Jun 30, 2025, 16:15
Jun 30, 2025, 15:49
Jun 30, 2025, 15:34
Jun 30, 2025, 15:15